Cellcolabs raises 49 MSEK

(Stockholm, a biotech impact startup on a mission to use advanced cell therapies to disrupt healthcare): Has raised 49 MSEK in a funding round from Norrsken, Sven Hagströmer, John Hedberg, Filip Engelbert, Jonas Nordlander, Susanna Campbell, Michaëla Berglund, member Fredrik Jung-Abbou and founding member Ash Pournouri. “Through a clear focus on high-quality cells and by scaling up production, we shall contribute to reduced prices for both research and treatment,” comments Mattias Bernow, CEO of Cellcolabs.